Literature DB >> 11843707

Attention-deficit/hyperactivity disorder.

Thomas J Spencer1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11843707     DOI： 10.1001/archneur.59.2.314

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  6 in total

1.  Oral Administration of Methylphenidate (Ritalin) Affects Dopamine Release Differentially Between the Prefrontal Cortex and Striatum: A Microdialysis Study in the Monkey.

Authors:  Tohru Kodama; Takashi Kojima; Yoshiko Honda; Takayuki Hosokawa; Ken-Ichiro Tsutsui; Masataka Watanabe
Journal:  J Neurosci       Date:  2017-02-02       Impact factor: 6.167

Review 2.  Molecular modulation of prefrontal cortex: rational development of treatments for psychiatric disorders.

Authors:  Nao J Gamo; Amy F T Arnsten
Journal:  Behav Neurosci       Date:  2011-06       Impact factor: 1.912

3.  Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors.

Authors:  Nao J Gamo; Min Wang; Amy F T Arnsten
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-09-01       Impact factor: 8.829

4.  Relationship between Health-Related Quality of Life and Physical Activity in Children with Hyperactivity.

Authors:  Julio Gallego-Méndez; Jorge Perez-Gomez; José Ignacio Calzada-Rodríguez; Ángel Manuel Denche-Zamorano; María Mendoza-Muñoz; Jorge Carlos-Vivas; Miguel Ángel Garcia-Gordillo; Jose C Adsuar
Journal:  Int J Environ Res Public Health       Date:  2020-04-18       Impact factor: 3.390

5.  Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate.

Authors:  Veronika Engert; Jens C Pruessner
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

6.  Reduced spontaneous eye blink rates in recreational cocaine users: evidence for dopaminergic hypoactivity.

Authors:  Lorenza S Colzato; Wery P M van den Wildenberg; Bernhard Hommel
Journal:  PLoS One       Date:  2008-10-22       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.